Wolverine Asset Management LLC Intercept Pharmaceuticals, Inc. Transaction History

Wolverine Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 01, 2023	SELL	$11.61 - $16.11 $96,479 - $133,874	-8,310 Reduced 31.97%	17,680 $218,000
Q3 2022 Nov 10, 2022	BUY	$12.21 - $19.7 $317,337 - $512,003	25,990 New	25,990 $362,000
Q2 2021 Aug 13, 2021	BUY	$15.46 - $24.5 $1.71 Million - $2.71 Million	110,574 Added 5339.16%	112,645 $2.25 Million
Q4 2020 Feb 12, 2021	BUY	$24.48 - $42.47 $43,060 - $74,704	1,759 Added 563.78%	2,071 $51,000
Q2 2020 Aug 13, 2020	BUY	$46.7 - $92.04 $14,570 - $28,716	312 New	312 $14,000
Q1 2018 May 15, 2018	SELL	$52.72 - $67.25 $1.73 Million - $2.21 Million	-32,807 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$58.2 - $72.76 $1.91 Million - $2.39 Million	32,807	32,807 $1.92 Million

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.